Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,205 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,005 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04686747 | COVID - 19 and Advanced Gastro-intestinal Cancer Treatment(COVID - AGICT) | completed | — | 2,000 | S.M. Misericordia HospitalOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT06189664 | Evaluation of the Effectiveness of Intraoperative Frozen Section on the Treatment of Suspected Gallbladder Cancer | completed | — | 37 | Imperial College LondonOTHER | 0 | Jan 3, 2024 |
| clinicaltrials |
| NCT01825603 | ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer | completed | Phase 1 | 17 | University of NebraskaOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT03219268 | A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms | completed | Phase 1 | 277 | MacroGenicsINDUSTRY | 8 | Dec 21, 2023 | clinicaltrials |
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | completed | Phase 1 | 117 | Corvus Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 21, 2023 | clinicaltrials |
| NCT06178848 | EEG Parameters Between Remimazolam- and Propofol-based Anesthesia | completed | N/A | 60 | Yonsei UniversityOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT03230318 | Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma(FIDES-01) | completed | Phase 2 | 148 | Basilea PharmaceuticaINDUSTRY | 11 | Dec 19, 2023 | clinicaltrials |
| NCT05546970 | Efficacy of the Transversus Abdominis Plane Block on Analgesia After Cephalic Duodeno-pancreatectomy(TAP-Block) | completed | — | 80 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT03340974 | Pilot Dose Escalation Trial of Stereotactic Body Radiation Therapy (SBRT) in Combination With GC4419 in Pancreatic Cancer | completed | Phase 1 / Phase 2 | 42 | Galera Therapeutics, Inc.INDUSTRY | 1 | Dec 15, 2023 | clinicaltrials |
| NCT02494037 | The Canadian/US Integrative Oncology Study(CUSIOS) | completed | — | 400 | The Canadian College of Naturopathic MedicineOTHER | 2 | Dec 14, 2023 | clinicaltrials |
| NCT04299048 | Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia. | completed | Phase 1 | 11 | PfizerINDUSTRY | 1 | Dec 14, 2023 | clinicaltrials |
| NCT05589480 | Machine Learning for Recurrence Risk of Pancreatic Cancer After Radical Resection(PaC) | completed | — | 226 | Luo CongOTHER | 1 | Dec 11, 2023 | clinicaltrials |
| NCT03189914 | RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer | completed | Phase 1 / Phase 2 | 46 | Processa PharmaceuticalsINDUSTRY | 1 | Dec 6, 2023 | clinicaltrials |
| NCT04237441 | The Results of Pancreatic Operations After the Implementation of Multidisciplinary Team Conference (MDT): | completed | — | 7,294 | Rigshospitalet, DenmarkOTHER | 0 | Nov 30, 2023 | clinicaltrials |
| NCT04893408 | Pancreatic Surgery in Elderly Patients | completed | — | 1,556 | Rigshospitalet, DenmarkOTHER | 0 | Nov 30, 2023 | clinicaltrials |
| NCT05595811 | Pancreatic and Periampullary Tumors in Greenland Inuit | completed | — | 2,326 | Rigshospitalet, DenmarkOTHER | 0 | Nov 30, 2023 | clinicaltrials |
| NCT06147154 | Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients | completed | — | 23 | Qilu Hospital of Shandong UniversityOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT02381249 | The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | completed | N/A | 40 | St. James's Hospital, IrelandOTHER | 2 | Nov 27, 2023 | clinicaltrials |
| NCT02231723 | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer | completed | Phase 1 | 139 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Nov 18, 2023 | clinicaltrials |
| NCT02703545 | International CAPS Registry: Pancreas Cancer Cases in Surveillance Programs(CAPS Registry) | completed | — | 58 | Johns Hopkins UniversityOTHER | 0 | Nov 18, 2023 | clinicaltrials |
| NCT03784677 | A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors | completed | Phase 1 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT04596865 | Recurrence After Whipple's (RAW) Study | completed | — | 1,484 | University Hospital Plymouth NHS TrustOTHER | 8 | Nov 18, 2023 | clinicaltrials |
| NCT02527434 | Study of Tremelimumab in Patients With Advanced Solid Tumors | completed | Phase 2 | 64 | AstraZenecaINDUSTRY | 5 | Nov 15, 2023 | clinicaltrials |
| NCT02232633 | A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer | completed | Phase 2 | 45 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Nov 14, 2023 | clinicaltrials |
| NCT02498665 | A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies | completed | Phase 1 | 24 | Sumitomo Pharma America, Inc.INDUSTRY | 1 | Nov 14, 2023 | clinicaltrials |
| NCT02264665 | OPALINE : A Study Of Morbidity And Mortality At 2 Years(OPALINE) | completed | — | 144 | PfizerINDUSTRY | 1 | Nov 13, 2023 | clinicaltrials |
| NCT04281511 | A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy | completed | — | 238 | National Cancer Center, KoreaOTHER_GOV | 1 | Nov 13, 2023 | clinicaltrials |
| NCT06129812 | An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer | completed | — | 1,132 | Seoul National University HospitalOTHER | 0 | Nov 13, 2023 | clinicaltrials |
| NCT05528614 | Evaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.(ReSiPaTNE) | completed | — | 51 | University Hospital, Strasbourg, FranceOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT02178436 | Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | Mohammed Najeeb Al HallakOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT03304210 | PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer(PIPAC-nabpac) | completed | Phase 1 | 20 | University Hospital, GhentOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT03260712 | Pembrolizumab in Biliary Tract Cancer | completed | Phase 2 | 50 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Nov 3, 2023 | clinicaltrials |
| NCT04210128 | Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment | completed | — | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT00020345 | Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas | completed | Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Oct 31, 2023 | clinicaltrials |
| NCT04257955 | COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer(COMMUNICARE) | completed | — | 32 | IRCCS San RaffaeleOTHER | 1 | Oct 31, 2023 | clinicaltrials |
| NCT02243358 | Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer | completed | Phase 2 | 24 | Henry Ford Health SystemOTHER | 1 | Oct 27, 2023 | clinicaltrials |
| NCT04247126 | A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors | completed | Phase 1 | 105 | Syros PharmaceuticalsINDUSTRY | 1 | Oct 27, 2023 | clinicaltrials |
| NCT00389610 | Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer | completed | Phase 2 | 56 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT02318095 | Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer | completed | N/A | 40 | Duke UniversityOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT03833661 | M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) | completed | Phase 2 | 159 | EMD Serono Research & Development Institute, Inc.INDUSTRY | 9 | Oct 25, 2023 | clinicaltrials |
| NCT02057146 | Endoscopic Evaluation of Premalignant Lesions in the Biliary Tract and Pancreatic Ducts | completed | N/A | 50 | Karolinska University HospitalOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT02162823 | Clinical Trial of Pancreatic Cancer in Stockholm.(SPP) | completed | — | 600 | Karolinska University HospitalOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT02767700 | NGS and TME for Evidence-based Treatment of Pancreatic Cancer(PePaCaKa-01) | completed | — | 39 | Karolinska University HospitalOTHER | 0 | Oct 24, 2023 | clinicaltrials |
| NCT06093009 | The Significance of Postoperative Muscle Wasting in Pancreatic Cancer | completed | — | 208 | National Cheng-Kung University HospitalOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT01401907 | Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies | completed | N/A | 351 | Massachusetts General HospitalOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03117920 | A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer(MinPAC) | completed | Phase 2 | 19 | Minneamrita Therapeutics LLCINDUSTRY | 1 | Oct 18, 2023 | clinicaltrials |
| NCT06080204 | Real-world Study on Adjuvant Octreotide Therapy in pNETs | completed | N/A | 411 | Changhai HospitalOTHER | 0 | Oct 18, 2023 | clinicaltrials |
| NCT02893930 | Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery | completed | Phase 2 | 13 | National Cancer Institute (NCI)NIH | 1 | Oct 17, 2023 | clinicaltrials |
| NCT05650918 | MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)(REACtiVe-2) | completed | Phase 1 | 22 | Joachim Aerts, MD PhDOTHER | 1 | Oct 12, 2023 | clinicaltrials |
| NCT01068327 | Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer | completed | Phase 1 | 46 | University of NebraskaOTHER | 1 | Oct 10, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Jan 3, 2024source: clinicaltrials